Cincinnati Wellness Review: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Cincinnati Wellness Review.

Press releases published on March 3, 2026

Sana Biotechnology Reports Fourth Quarter and Full Year 2025 Financial Results and Business Updates
LifeMD to Participate in Two Investor Conferences During March
Fate Therapeutics to Participate in Leerink Partners 2026 Global Healthcare Conference
Dianthus Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Vaxart to Host Upcoming Conference Calls
Lexicon Pharmaceuticals to Participate in Three Upcoming March Investor Conferences
TimelyCare Honored as Virtual Student Health and Wellness Services Company of the Year 2026 by Education Insider
Wacoal Hosts Bra Fittings Nationwide to Support the Fight Against Breast Cancer, in discussion with YourUpdateTV
Testosterone Booster Supplement for Men Over 50 — TestoPrime Medically Accredited by Clinicians' Choice in 2026
AlayaCare empowers home care agencies to reclaim 80% of time and costs with new AI automation
AlayaCare permet aux agences de soins à domicile de récupérer jusqu’à 80 % de leur temps et de leurs coûts grâce à l’automatisation par l’IA
GHSA, BusPatrol Release National Action Plan for School Bus Safety
Smith+Nephew to showcase advanced Orthopaedic Handheld Robotics, Reconstruction and Trauma technologies during AAOS 2026
Hypersanté Hosts First Francophone Summit on Longevity and Biohacking in Paris
Sympathiq Launches Well-Being Marketplace Connecting UK Residents with Certified Mental Health Specialists
Suzanne Nora Johnson Joins Wellcome Leap Board of Directors
Eric Favre Reaches One Million Customers in Sports Nutrition After 30 Years of French Manufacturing
Spryte Medical Announces First Participants Enrolled in the INSYTE Trial at Baptist Health Jacksonville
PCCA Appoints Matt Line as First Chief Marketing Officer and Promotes Kim Speairs to Vice President of Communications
Persevere Therapeutics Launches as a Clinical-Stage Oncology Company with a Novel Phase 1b/2a Agent and Announces First Close of Seed Financing

Share this page:

Sign up for:

Cincinnati Wellness Review

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.